标题
Pharmacogenomics of the triazole antifungal agent voriconazole
作者
关键词
-
出版物
PHARMACOGENOMICS
Volume 12, Issue 6, Pages 861-872
出版商
Future Medicine Ltd
发表日期
2011-06-21
DOI
10.2217/pgs.11.18
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Modulators of Very Low Voriconazole Concentrations in Routine Therapeutic Drug Monitoring
- (2011) Arwa Hassan et al. THERAPEUTIC DRUG MONITORING
- Potential impact of cytochrome P450 3A5 in human liver on drug interactions with triazoles
- (2010) Hiroshi Yamazaki et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Linkage disequilibrium between the CYP2C19*17 allele and wildtype CYP2C8 and CYP2C9 alleles: identification of CYP2C haplotypes in healthy Nordic populations
- (2010) Rasmus S. Pedersen et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Effect of cytochrome P450 2C19 genotype on voriconazole exposure in cystic fibrosis lung transplant patients
- (2010) Maud Berge et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Effects of erythromycin on voriconazole pharmacokinetics and association with CYP2C19 polymorphism
- (2010) Hui-Yan Shi et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Voriconazole Pharmacokinetics in Liver Transplant Recipients
- (2009) H. J. Johnson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics, metabolism and bioavailability of the triazole antifungal agent voriconazole in relation to CYP2C19 genotype
- (2009) Ina Scholz et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacogenetics of CYP2C19: functional and clinical implications of a new variant CYP2C19*17
- (2009) Alain Li-Wan-Po et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Clinical Relevance of the Pharmacokinetic Interactions of Azole Antifungal Drugs with Other Coadministered Agents
- (2009) Roger J. M. Brüggemann et al. CLINICAL INFECTIOUS DISEASES
- Correlation between voriconazole trough plasma concentration and hepatotoxicity in patients with different CYP2C19 genotypes
- (2009) Kazuaki Matsumoto et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Voriconazole pharmacokinetic variability in cystic fibrosis lung transplant patients
- (2009) M. Berge et al. Transplant Infectious Disease
- Inhibition of Voriconazole Metabolism by Chloramphenicol in an Adolescent with Central Nervous System Aspergillosis
- (2008) V. Hafner et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antifungal Therapeutic Drug Monitoring: Established and Emerging Indications
- (2008) D. Andes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetic Analysis of Voriconazole Plasma Concentration Data from Pediatric Studies
- (2008) M. O. Karlsson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comprehensive In Vitro Analysis of Voriconazole Inhibition of Eight Cytochrome P450 (CYP) Enzymes: Major Effect on CYPs 2B6, 2C9, 2C19, and 3A
- (2008) S. Jeong et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Limited frequency of the CYP2C19*17 allele and its minor role in a Japanese population
- (2008) Katsuyoshi Sugimoto et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacokinetics and tolerability of voriconazole and a combination oral contraceptive co-administered in healthy female subjects
- (2008) Emma Andrews et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Role of Flavin-Containing Monooxygenase in Oxidative Metabolism of Voriconazole by Human Liver Microsomes
- (2008) S. B. Yanni et al. DRUG METABOLISM AND DISPOSITION
- Cytochrome P450 2C19 genetic polymorphisms in Ugandans
- (2008) Jun Miura et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- The CYP2C19 ultra-rapid metabolizer genotype influences the pharmacokinetics of voriconazole in healthy male volunteers
- (2008) Guo Wang et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- CYP2C19Genotype Is a Major Factor Contributing to the Highly Variable Pharmacokinetics of Voriconazole
- (2008) Johanna Weiss et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Need for reassessment of reportedCYP2C19allele frequencies in various populations in view ofCYP2C19*17discovery: the case of Greece
- (2008) Georgia Ragia et al. PHARMACOGENOMICS
- Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes
- (2007) A. Pascual et al. CLINICAL INFECTIOUS DISEASES
- Pharmacokinetic Interaction Between Voriconazole and Efavirenz at Steady State in Healthy Male Subjects
- (2007) Ping Liu et al. JOURNAL OF CLINICAL PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started